arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Thursday 1 July 2021

All mentioned times are in CET.

Thursday 01 Jul

08:25

Opening - by Presidents of EHNS, ESMO and ESTRO

Wojciech Golusinski, EHNS & Solange Peters, ESMO & Ben Slotman, ESTRO

Presidential Lecture

Chair: Wojciech Golusinski, Poland

08:40

Surgical Innovation: Essential for Optimal Multidisciplinary Care of Oropharyngeal Cancer

Chris Holsinger, USA

09:00

Best Presentation from Young Scientist’s Forum

Chairs: Pawel Golusinksi & Amanda Psyrri

SESSION 1: FUTURE OF SURGICAL TREATMENTS.

Chair: Jan Klozar, Czech Republic & Moderator: René Leemans, The Netherlands

09:15

Is there a role of TORS in management of p16+ unknown primary cancer of the H&N?

Vinidh Paleri, United Kingdom

09:35

3D robotic like surgery

Giovanni Succo, Italy

09:55

Novel techniques for endoscopic skull base surgery

Antoine Moya-Plana, France

10:15

Image guided surgery

Max Witjes, The Netherlands

10:35

Coffee Break

SESSION 2: DEVELOPMENTS IN GENETICS AND DIAGNOSIS

Chair: Ruud Brakenhoff, The Netherlands & Moderator: Pierre Saintigny, France

11:05

Intratumor genetic heterogeneity: current status and clinical relevance.

Patrick Pauwels, Belgium

11:25

Liquid biopsy analysis in H&N cancer

Ingeborg Tinhofer-Keilholz, Germany

Proferred papers related to sessions 1-2

Chair: Robert Takes, The Netherlands & Moderator: Ahmet O. IKIZ, Turkey

11:50

1.1 Molecular patterns in salivary duct carcinoma identify prognostic subgroups

Simon A Mueller, Switzerland

12:00

1.2 Ex vivo functional assay for predicting radiation treatment response in squamous cell carcinoma of the head and neck.

M.E. Capala, The Netherlands

12:10

1.3 Three-dimensional margin assessment in head and neck malignancies

Jens Debacker, Belgium

12:20

1.4 EGFR-targeted fluorescence guided surgery in head and neck squamous cell carcinoma

J.G. de Wit, the Netherland

12:40

Lunch break & visit virtual sponsor booth

12:50

Satellite symposium

Visit: https://www.echno-ichno2021.org/sponsored-symposia-2/

SESSION III: RECURRENT HEAD AND NECK CANCER-Salvage treatments in recurrent head and neck cancer

Chair: Vinidh Paleri, United Kingdom & Moderator: Jean-François Daisne, Belgium

14:00

Salvage surgery for locally recurrent head and neck cancer

Miguel Quer, Spain

14:20

Locoregional reirradiation for recurrent head and neck cancer in the IMRT and SBRT era.

Vincent Gregoire, France

14:40

Systemic therapy as monotherapy and in combination in head and neck cancer

Jan Vermorken, Belgium

PANEL: Salvage treatments in recurrent head and neck cancer: interactive case discussions

Moderators: Valentino Valentini, Italy & Antoine Digonnet, Belgium & Giovanni Succo, Italy - Case discussion

15:00

Panelists

Radiotherapy: Kenneth Jensen, Denmark & Oncology: Sjoukje Oosting, The Netherlands & Oncology: Amanda Psyrri, Greece, Surgery: Gilles Dolivet, France; Surgery: Gregorio Sanchez Aniceto, Spain

15:40

Coffee Break

Proferred papers session 3

Chair: Antti Mäkitie, Finland & Moderator: Ben-Zion Joshua, Israel

16:15

3.1 A circulating biomarker for the early detection of recurrent oral cancer.:

Cathie Garnis, Canada

16:25

3.2 Salvage Treatment in Isolated Regional Recurrent Head and Neck Squamous Cell Carcinoma

Roland Giger, Switzerland

16:35

3.3 Nasopharyngeal brush Epstein barr viral DNA in the detection of locally recurrent nasopharyngeal cancer

Jason Chan, Hong Kong

16:45

Concluding remarks

Ben-Zion Joshua, Israel

New data from randomised trials

Chair: Ana Varges Gomes, Portugal & Moderator: Andreas Dietz, Germany

17:00

Introduction by the chair

17:05

A DAHANCA-EORTC blind randomised multicentric study of concomitant chemo-radiotherapy with or without the hypoxic cell sensitiser Nimorazole for locally advanced p16-negative head and neck SCC.

Vincent Grégoire, France

17:20

Results of DARS: a randomised phase III trial of dysphagia-optimised intensity modulated radiotherapy (DO-IMRT) versus standard IMRT (S-IMRT) in oropharyngeal (OPC) and hypopharyngeal (HPC) cancer.

Chris Nutting, United Kingdom

17:35

Efficacy of Hyperbaric Oxygen in the Treatment of Osteoradionecrosis of the Mandible. Results from the combined clinical trials DAHANCA-21 and NWHHT2009-1.

François Dieleman, The Netherlands

SESSION 4: SALIVARY GLAND TUMORS

Chair: Marc Hamoir, Belgium & Moderator: Gerhard Hüber, Switzerland - Case discussion

17:50

Keynote lecture: Histology-driven surgery in parotid carcinoma: fact or fiction?

Vincent Vanderpoorten, Belgium

18:10

Panelists

Surgery: Sefik Hosal, Turkey & Radiotherapy: Jean Bourhis, Switzerland & Oncology: Laura Locati, Italy & Pathology: Andrzej Marszałek, Poland

18:50

End of the congress day